Renke Maas

8.7k total citations
156 papers, 6.7k citations indexed

About

Renke Maas is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Geriatrics and Gerontology. According to data from OpenAlex, Renke Maas has authored 156 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Cardiology and Cardiovascular Medicine, 60 papers in Physiology and 26 papers in Geriatrics and Gerontology. Recurrent topics in Renke Maas's work include Nitric Oxide and Endothelin Effects (57 papers), Pharmaceutical Practices and Patient Outcomes (25 papers) and Cardiovascular Issues in Pregnancy (23 papers). Renke Maas is often cited by papers focused on Nitric Oxide and Endothelin Effects (57 papers), Pharmaceutical Practices and Patient Outcomes (25 papers) and Cardiovascular Issues in Pregnancy (23 papers). Renke Maas collaborates with scholars based in Germany, United States and Italy. Renke Maas's co-authors include Rainer H. Böger, Edzard Schwedhelm, Friedrich Schulze, Carmine Zoccali, Martin F. Fromm, Giovanni Tripepi, Francesca Mallamaci, Ralf A. Benndorf, Lorenzo Malatino and Ulrich Riederer and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Renke Maas

148 papers receiving 6.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renke Maas Germany 47 2.9k 2.3k 908 670 669 156 6.7k
Klaus K. Witte United Kingdom 48 5.3k 1.8× 1.6k 0.7× 1.1k 1.2× 986 1.5× 865 1.3× 316 9.3k
Joe Collier United Kingdom 34 3.5k 1.2× 4.0k 1.7× 775 0.9× 734 1.1× 806 1.2× 97 7.4k
Arduino A. Mangoni Australia 51 2.7k 0.9× 1.4k 0.6× 1.5k 1.6× 1.2k 1.8× 1.7k 2.5× 438 11.2k
James M. Ritter United Kingdom 43 3.3k 1.1× 1.5k 0.6× 1.1k 1.2× 1.0k 1.5× 601 0.9× 121 6.5k
Michael E. Widlansky United States 33 2.8k 1.0× 1.9k 0.8× 1.6k 1.8× 688 1.0× 581 0.9× 85 7.1k
John D. Horowitz Australia 60 9.1k 3.1× 1.9k 0.8× 1.4k 1.6× 1.5k 2.2× 1.1k 1.6× 380 13.5k
Yoshihiro Kokubo Japan 50 2.3k 0.8× 1.0k 0.4× 1.2k 1.3× 1.2k 1.7× 507 0.8× 247 8.2k
Roberto Pedrinelli Italy 39 3.6k 1.3× 1.3k 0.6× 956 1.1× 958 1.4× 761 1.1× 255 7.1k
Reinhold Kreutz Germany 48 5.7k 2.0× 1.6k 0.7× 1.8k 2.0× 1.3k 1.9× 584 0.9× 398 11.0k
Isabella Sudano Switzerland 38 3.1k 1.1× 1.5k 0.6× 483 0.5× 866 1.3× 510 0.8× 133 5.7k

Countries citing papers authored by Renke Maas

Since Specialization
Citations

This map shows the geographic impact of Renke Maas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renke Maas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renke Maas more than expected).

Fields of papers citing papers by Renke Maas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renke Maas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renke Maas. The network helps show where Renke Maas may publish in the future.

Co-authorship network of co-authors of Renke Maas

This figure shows the co-authorship network connecting the top 25 collaborators of Renke Maas. A scholar is included among the top collaborators of Renke Maas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renke Maas. Renke Maas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keller, Max, et al.. (2024). Differential uptake of arginine derivatives by the human heteromeric amino acid transporter b0,+AT-rBAT (SLC7A9-SLC3A1). Naunyn-Schmiedeberg s Archives of Pharmacology. 398(4). 4419–4434.
2.
3.
Moser, Carlee, Meredith S. Duncan, Edzard Schwedhelm, et al.. (2021). Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study. PLoS ONE. 16(9). e0254577–e0254577. 1 indexed citations
4.
Rodionov, Roman N., et al.. (2020). Transport of L-Arginine Related Cardiovascular Risk Markers. Journal of Clinical Medicine. 9(12). 3975–3975. 30 indexed citations
5.
Maas, Renke, Vanessa Xanthakis, Thomas Göen, et al.. (2017). Plasma Nitrate and Incidence of Cardiovascular Disease and All‐Cause Mortality in the Community: The Framingham Offspring Study. Journal of the American Heart Association. 6(11). 31 indexed citations
6.
Oppici, Elisa, Jens Martens‐Lobenhoffer, Natalia Jarzebska, et al.. (2016). A Novel Pathway for Metabolism of the Cardiovascular Risk Factor Homoarginine by alanine:glyoxylate aminotransferase 2. Scientific Reports. 6(1). 35277–35277. 30 indexed citations
7.
Pfistermeister, Barbara, Lothar Terfloth, Renke Maas, et al.. (2014). The effect object paradigm--a means to support medication safety with clinical decision support.. PubMed. 205. 1065–9. 3 indexed citations
8.
Dormann, Harald, Fabian Müller, Barbara Pfistermeister, et al.. (2013). Adverse Drug Events in Older Patients Admitted as an Emergency. Deutsches Ärzteblatt international. 110(13). 213–9. 68 indexed citations
9.
Siegerink, Bob, Renke Maas, Carla Y. Vossen, et al.. (2012). Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study. Clinical Research in Cardiology. 102(3). 193–202. 57 indexed citations
10.
Lüneburg, Nicole, Vanessa Xanthakis, Edzard Schwedhelm, et al.. (2011). Reference Intervals for Plasma L-Arginine and the L-Arginine:Asymmetric Dimethylarginine Ratio in the Framingham Offspring Cohort. Journal of Nutrition. 141(12). 2186–2190. 68 indexed citations
11.
Böger, Rainer H., Heinz G. Endres, Edzard Schwedhelm, et al.. (2010). Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease. Journal of Internal Medicine. 269(3). 349–361. 47 indexed citations
12.
Schwedhelm, Edzard, et al.. (2010). Redox‐generated isoprostanes are associated with residual platelet activity in aspirin‐treated patients with stable coronary heart disease. Journal of Thrombosis and Haemostasis. 8(12). 2662–2670. 14 indexed citations
13.
Jacobi, Johannes, Renke Maas, Arturo J. Cardounel, et al.. (2010). Dimethylarginine Dimethylaminohydrolase Overexpression Ameliorates Atherosclerosis in Apolipoprotein E-Deficient Mice by Lowering Asymmetric Dimethylarginine. American Journal Of Pathology. 176(5). 2559–2570. 55 indexed citations
14.
Böger, Rainer H., Lisa Sullivan, Edzard Schwedhelm, et al.. (2009). Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community. Circulation. 119(12). 1592–1600. 287 indexed citations
15.
Rau, Thomas, et al.. (2007). P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease. British Journal of Clinical Pharmacology. 65(4). 540–547. 25 indexed citations
16.
Benndorf, Ralf A., Ursula M. Gehling, Renke Maas, et al.. (2007). Mobilization of Putative High-Proliferative-Potential Endothelial Colony-Forming Cells during Antihypertensive Treatment in Patients with Essential Hypertension. Stem Cells and Development. 16(2). 329–338. 26 indexed citations
17.
Maas, Renke, et al.. (2007). A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue. Journal of Chromatography B. 851(1-2). 220–228. 23 indexed citations
18.
Schwedhelm, Edzard, Renke Maas, Donald Jung, et al.. (2007). Pharmacokinetic and pharmacodynamic properties of oral L‐citrulline and L‐arginine: impact on nitric oxide metabolism. British Journal of Clinical Pharmacology. 65(1). 51–59. 379 indexed citations
19.
Maas, Renke, Frank Sonntag, Mirosław Dłużniewski, et al.. (2004). Suppression of paroxysmal atrial tachyarrhythmias ? results of the SOPAT trial. European Heart Journal. 25(16). 1395–1404. 85 indexed citations
20.
Zoccali, Carmine, Francesca Mallamaci, Renke Maas, et al.. (2002). Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney International. 62(1). 339–345. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klaus K. Witte Breakdown of academic impact, for papers by Joe Collier Breakdown of academic impact, for papers by Arduino A. Mangoni Breakdown of academic impact, for papers by James M. Ritter Breakdown of academic impact, for papers by Michael E. Widlansky Breakdown of academic impact, for papers by John D. Horowitz Breakdown of academic impact, for papers by Yoshihiro Kokubo Breakdown of academic impact, for papers by Roberto Pedrinelli Breakdown of academic impact, for papers by Reinhold Kreutz Breakdown of academic impact, for papers by Isabella Sudano
Rankless by CCL
2026